L-asparaginase (L-ASNase) has been a cornerstone of acute lymphoblastic leukemia (ALL) therapy for decades, owing to its ability to deplete circulating asparagine, an amino acid essential for leukemic cell proliferation [1,2,3,4,5,6,7,8]. Here, ASPG is linked to acute lymphoblastic leukemia.